Cytomegalovirus infectivity in whole blood following leukocyte reduction by filtration

American Journal of Clinical Pathology

Volumn 116, Issue 1, 2001, Pages 52-55

  Lipson, Steven M ^a,c   Shepp, David H ^a   Match, Mark E ^a   Axelrod, Frederick B ^b,d   Whitbread, John A ^b,e  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b PALL CORPORATION   (United States)

^c Virology Consultants Inc   (United States)

^d ABBOTT LABORATORIES   (United States)

^e Cytometrix International   (United States)

Author keywords

Cytomegalovirus; Filtration; Leukocyte reduction

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIGEN DETECTION; ARTICLE; BLOOD DONOR; BLOOD FILTRATION; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CYTOMEGALOVIRUS; ERYTHROCYTE; FEMALE; HUMAN; LEUKOCYTE; MALE; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS LOAD;

ADULT; BLOOD DONORS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEMOFILTRATION; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; VIRAL LOAD; VIREMIA;

EID: 0034961719     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/PVFR-DDWE-302T-WFA1     Document Type: Article

References (28)

1. Begue S. La deleucocytation [in French]. Transfus Clin Biol. 1998;5:411-414.
2. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood. 1995;86:3598-3603.
3. Davoli EH, Lipson SM, Match ME, et al. Evaluation of the PrimeCapture CMV DNA Detection Plate System for the detection of cytomegalovirus from clinical specimens. J Clin Microbiol. 1999;37:2587-2591.
4. Gott JP, Cooper WA, Schmidt FE Jr, et al. Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategies. Ann Thorac Surg. 1998;66:747-754.
5. Gu YJ, de Vries AJ, Vos P, et al. Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit. 1999;67:604-609.
6. Hillyer CD. The role of leukoreduction in minimizing the risk of transfusion transmission of cell associated infectious agents. The compendium: a selection of short topic presentations from the technical/clinical and scientific tracks. 52nd Annual Meeting of the American Association of Blood Banks; 1999; San Francisco, CA.
7. Pamphilon DH, Foot ABM, Adeodu A. Prophylaxis and prevention of CMV infection in BM allograft recipients: leucodepleted platelets are equivalent to those from CMV seronegative donors [letter]. Bone Marrow Transplant. 1999;23:S66.
8. Podnos YD, Williams RA. Current risks for blood viral illness in blood transfusions. West J Med. 1998;168:36-37.
9. Larsson S, Soderberg-Naucler C, Wang F-Z, et al. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion. 1998;38:271-278.
10. Zhang LJ, Hanff P, Rutherford C, et al. Detection of human cytomegalovirus DNA, RNA and antibody in normal donor blood. J Infect Dis. 1995;171:1002-1006.
11. Bordin JO, Fabron JA. Clinical applications of leukocyte filters. Rev Assoc Med Bras. 1997;43:205-208.
12. Klein MA, Frigg R, Raeber AJ, et al. PrP expression in B lymphocytes is not required for prion neuroinvasion. Nat Med. 1999;84:1429-1433.
13. Sayers MH. Transfusion-transmitted viral infections other than hepatitis and human immunodeficiency virus infection, cytomegalovirus, Epstein-Barr virus, human herpesvirus 6, and human parvovirus B19. Arch Pathol Lab Med. 1994;118:346-349.
14. Lipson SM, Match ME, Toro AI, et al. Application of a standardized cytomegalovirus antigenemia assay in the management of patients with AIDS. Diagn Microbiol Infect Dis. 1998;32:75-79.
15. Lipson SM. The neutralization test. In: Isenberg HD, ed. Clinical Microbiology Procedures Handbook. Washington, DC: American Society for Microbiology; 1992;2:8.14.1-8.14.8.
16. Lipson SM. Leukocyte stabilization reagent for use in the cytomegalovirus pp65 antigenemia assay [letter]. J Clin Microbiol. 1999;37:2742.
17. Shepp DH, Match ME, Lipson SM, et al. A fifth human cytomegalovirus glycoprotein B genotype. Res Virol. 1998;149:109-114.
18. Bevan C, Sammons C, Sweet C. Investigation of murine cytomegalovirus latency and reactivation in mice using viral mutants and the polymerase chain reaction. J Med Virol. 1996;48:308-320.
19. Lo CY, Ho KN, Yuen KY, et al. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay. Clin Transpl. 1997;11:286-293.
20. Mas V, Alvarellos T, Albano S, et al. Utility of cytomegalovirus viral load in renal transplant patients in Argentina. Transplantation. 1999;67:1050-1055.
21. Dodd RY. Impact of leukodepletion on infections other than cytomegalovirus. Curr Stud Hematol Blood Transfus. 1994;(60):53-63.
22. James DJ, Sikotra S, Sivakumaran M, et al. The presence of free infectious cytomegalovirus (CMV) in the plasma of donated CMV-seropositive blood and platelets. Transfus Med. 1997;7:123-126.
23. Einsenfeld L, Silver H, McLaughlin J, et al. Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by removal of white cells from blood. Transfusion. 1992;32:205-209.
24. Lee TH, Sakahara NS, Fiebig EW, et al. Quantitation of white cell subpopulations by polymerase chain reaction using frozen whole-blood samples. Viral Activation Transfusion Study. Transfusion. 1998;38:262-270.
25. Narvios AB, Przepiorka D, Tarrand J, et al. Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients. Bone Marrow Transplant. 1998;6:575-577.
26. Pamphilon DH, Rider JR, Barbara JAJ, et al. Prevention of transfusion-transmitted cytomegalovirus infection. Transfus Med. 1999;9:115-123.
27. Van Prooijen HC, Visser JJ, van Oostendorp W, et al. Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white blood cells from blood components with high-affinity filters. Br J Haematol. 1994;84:144-147.
28. Lipson SM, Shepp DH, Whitbread J, et al. Cytomegalovirus infectivity in whole blood following leukocyte reduction by filtration. Poster presented at the 52nd Annual Meeting of the American Association of Blood Banks; November 6-10, 1999; San Francisco, CA. Poster No. S344-P.